Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGXT | P21549 | 1/20 | 0.55 |
| ▸ | AOC3 | Q16853 | 3/20 | 0.44 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.44 |
| ▸ | MAOA | P21397 | 2/20 | 0.44 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.44 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | PRKCI | P41743 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | BCL2 | P10415 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | KDM1A | O60341 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL28572120 | 0.98 | AGXT (0.53) | AGXTAOC3GGPS1MAOACYP11B1 | |
| SCHEMBL16675040 | 0.96 | AGXT (0.52) | AGXTAOC3GGPS1MAOACYP11B1 | |
| SCHEMBL16675053 | 0.96 | AGXT (0.52) | AGXTAOC3GGPS1MAOACYP11B1 | |
| SCHEMBL1310731 | 0.93 | TSHR (0.48) | AGXTAOC3GGPS1TAAR1HRH3 | |
| SCHEMBL1309244 | 0.88 | TAAR1 (0.48) | AGXTGGPS1TAAR1PRKCITSHR | |
| SCHEMBL14590080 | 0.87 | AGXT (0.45) | AGXTAOC3GGPS1MAOATAAR1 | |
| SCHEMBL13857073 | 0.86 | TSHR (0.44) | AGXTTAAR1HRH3PRKCITSHR | |
| Biphenyl SCHEMBL27563359 | 0.85 | ALDH1A1 (0.53) | AGXTTAAR1CYP19A1TSHRALDH1A1 | |
| SCHEMBL3832589 | 0.85 | TAAR1 (0.50) | AGXTAOC3TAAR1PRKCI | |
| SCHEMBL5486041 | 0.83 | GRIN2D (0.47) | AGXTMAOACYP11B1CYP11B2TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105218377-A | A kind of Hydroxytyrosol NO donor derivative and its preparation method and application | UNIV XI AN JIAOTONG | 2016-01-06 | — | — | CN | claimed |
| CN-103155949-A | Pesticidal mixtures | BASF SE | 2013-06-19 | — | — | CN | claimed |
| US-20230331654-A1 | COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| CN-109970635-B | Preparation method and application of aminopyridine derivative | 万华化学集团股份有限公司 | 2020-07-28 | — | — | CN | disclosed |
| CN-111377849-A | Compound, pharmaceutically acceptable salt thereof and medical application thereof | 中国人民解放军军事科学院军事医学研究院 | 2020-07-07 | — | — | CN | disclosed |
| US-20200040025-A1 | URIDINE NUCLEOSIDE DERIVATIVES, COMPOSITIONS AND METHODS OF USE | TUFTS UNIVERSITY | 2020-02-06 | — | — | US | disclosed |
| CN-109970635-A | A kind of aminopyrazole derivatives preparation method and applications | 万华化学集团股份有限公司 | 2019-07-05 | — | — | CN | disclosed |
| WO-2018058148-A1 | URIDINE NUCLEOSIDE DERIVATIVES, COMPOSITIONS AND METHODS OF USE | TUFTS UNIVERSITY (US) | 2018-03-29 | — | — | WO | disclosed |
| CN-105594717-A | Pesticidal mixture | BASF SE | 2016-05-25 | — | — | CN | disclosed |
| CN-105218377-A | A kind of Hydroxytyrosol NO donor derivative and its preparation method and application | UNIV XI AN JIAOTONG | 2016-01-06 | — | — | CN | disclosed |
| CN-104604873-A | Fungicidal mixtures containing substituted 1-methyl pyrazol-4-yl carboxylic acid anilides | BASF AG | 2015-05-13 | — | — | CN | disclosed |
| US-5578634-A | SEPTIC SHOCK TREATMENT | ELI LILLY AND COMPANY (US) | 1996-11-26 | — | — | US | disclosed |
| CN-1130180-A | Amino (thio) ether derivative | MERCK PATENT AG (DE) | 1996-09-04 | — | — | CN | disclosed |
| WO-1996016058-A1 | AMINOMETHYL ARYL COMPOUNDS; DOPAMINE RECEPTOR SUBTYPE SELECTIVE LIGANDS | NEUROGEN CORPORATION (US) | 1996-05-30 | — | — | WO | disclosed |
| EP-0707007-A1 | Amino(thio)ether derivatives as CNS active agents | MERCK PATENT GmbH (DE) | 1996-04-17 | — | — | EP | disclosed |
| EP-0675110-A1 | 1H-Indole-3-glyoxylamide sPLA2 inhibitors | ELI LILLY AND COMPANY (US) | 1995-10-04 | — | — | EP | disclosed |
| CN-1098714-A | The 1H-indole-3-acetic acid hydrazide spla 2 inhibitors | LILLY CO ELI (US) | 1995-02-15 | — | — | CN | disclosed |
| EP-0620214-A1 | 1H-indole-3-acetic acid hydrazide sPLA2 inhibitors | ELI LILLY AND COMPANY (US) | 1994-10-19 | — | — | EP | disclosed |
| US-4668792-A | Intermediates to insecticidal [1,1'-biphenyl]-3-ylmethyl esters | FMC CORPORATION (US) | 1987-05-26 | — | — | US | disclosed |
| US-4139631-A | VASODILATORS, ANTISPASMODICS | BOTTU (FR) | 1979-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230331654-A1 | COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF | OCIAD1, OCIAD2, ORAI2 | AGXT 3684/4885AOC3 270/4885GGPS1 1170/4885 |
| US-20200040025-A1 | URIDINE NUCLEOSIDE DERIVATIVES, COMPOSITIONS AND METHODS OF USE | P2RY6, UPP1, UMPS | AGXT 4247/4885AOC3 2731/4885GGPS1 437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.